local_hospital

Barcelonabeta Brain Research Center

Address
Calle De Wellington 30, 08005 Barcelona, Spain

Barcelonabeta Brain Research Center - Alzheimer's Disease Research

Barcelonabeta Brain Research Center is a leading institution dedicated to advancing the understanding and treatment of Alzheimer's Disease, with particular emphasis on preclinical stages of the disease. The center conducts sophisticated neuroimaging studies and therapeutic interventions through the ALFA (Alzheimer and Families) research platform, focusing on individuals at risk for developing Alzheimer's before symptoms appear.

  • Advanced PET imaging studies using tau and amyloid tracers to characterize early pathological changes in Alzheimer's Disease
  • Clinical trials of innovative immunotherapies targeting phosphorylated tau and amyloid beta proteins
  • Longitudinal assessment of cognitive decline in preclinical Alzheimer's Disease populations
  • Investigation of disease-modifying therapies in early-stage Alzheimer's Disease

The center employs cutting-edge molecular imaging techniques, including 18F-Flutemetamol PET for amyloid detection, 18F-RO6958948 PET for tau aggregates, and 18F-FDG PET for glucose metabolism assessment. Their research portfolio includes pioneering trials of novel therapeutics such as BAN2401, JNJ-64042056, and remternetug, aimed at preventing or slowing disease progression in individuals with elevated amyloid levels before significant cognitive impairment occurs.

Site Overview

assignment
7
connected trials
corporate_fare
4
sponsors
science
14
IMPs

Activity Indicator

Last 6 months

1
Trials started
0% vs previous period.
1
Trials started 6–12 months ago
7
Total trials linked
Active
trending_flatStable0%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
4
Sponsors (total)
4
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +1 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 567 other sites in Spain

description
Trial volume
7
Outperforms 69% of sites
public
Therapeutic diversity
2areas
Outperforms 49% of sites
groups
Sponsor diversity
4sponsors
Outperforms 65% of sites

Therapeutic Area Benchmark — Spain

Select a therapeutic area to compare against other sites in Spain.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Spain

Market Share

Country: Spain

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Barcelonabeta Brain Research Center

lock Showing 1 of 7 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Characterization of Astrocyte Reactivity Using [18F]F-DED PET Imaging in Alzheimer's Disease and Other Neurodegenerative DisordersBarcelonabeta Brain Research CenterPhase IIRecruitingJun 2026

IMP list

lock Showing 1 of 14 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3',4'-D]Pyrrole1Unknown2024-12-182024-12-18

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.